Aspen surged 5.6% after the group said it has received approval from the South African Health Products Regulatory Authority and will start the release of the first commercial batches of human insulin manufactured for sale in South Africa.
MarketsPREMIUM
STOCK HIGHLIGHT | Aspen gets shot in the arm
South African regulator clears Aspen’s locally made insulin for market
Editor’s Choice
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.